First ALS Research Group Meeting to occur this September in Minneapolis
The first ALS Research Group Meeting will take place this September 17-20, 2014 in Minneapolis, MN. For program information and registration, click here.…
Trial News & Events
Announcing the Pooled Resources Open Access ALS Clinical Trial (PRO-ACT) Database
It has been announced that the largest ALS clinical trial data base, PRO-ACT, is now openly available to research around the world. Read more…
NEALS Members Attend the American Academy of Neurology Annual Meeting in Philadelphia
The 66th American Academy of Neurology Annual Meeting was held April 26th-May 3rd at the Pennsylvania Convention Center in Philadelphia, PA.
Cytokinetics, Inc. Announces Results from Benefit-ALS
Results from the study BENEFIT-ALS were presented at the 66th AAN Meeting in Philadelphia, PA on April 29, 2014.
Recent Discovery Helps to Identify Common Problems in ALS
Harvard stem cell scientists have discovered that retigabine has effects in preclinical models of motor neuron disorder. The researchers are collaborating with Massachusetts General Hospital and the Northeast ALS Consortium to design an initial clinical trial in ALS. Click here for the full article.…
Research Ambassador Featured in Regional Magazine
NEALS Research Ambassador Madeline Kennedy has been profiled in the current issue of Capital Region Living, an Albany, NY-based lifestyle magazine. Click here to read how Kennedy hasn't let ALS darken her bright spirit.…
South African Rugby Star to Participate in ALS Studies at Massachusetts General Hospital
Former Springboks captain Joost Van der Westhuizen, who was diagnosed with ALS in 2011, will be traveling to the US to participate in ALS clinical studies. Read more >>…
NEALS Executive Committee Election Results
The Northeast ALS Consortium is pleased to announce the results of the election for the Co-Chair, Investigator, and Evaluator positions on the NEALS Executive Committee.
Annual Meeting Highlights Clinical Trials Progress
The 12th Annual Meeting of NEALS was the largest and most information-packed meeting yet. Over 300 clinicians, nurses, therapists, and researchers came together to take stock of the many efforts being coordinated by NEALS, and to accelerate the pace of clinical research in ALS.
NEALS Co-Founder Dr. Jeremy Shefner Steps Down After 18 Years
“Leading NEALS is one of the things in my professional career I am proudest of,” says Shefner.